{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T16:03:33Z","timestamp":1699027413407},"reference-count":46,"publisher":"Tohoku University Medical Press","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tohoku J. Exp. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.1620\/tjem.228.305","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T22:33:10Z","timestamp":1351895590000},"page":"305-315","source":"Crossref","is-referenced-by-count":6,"title":["Anti-Atherogenic Effects of the Combination Therapy with Olmesartan and Azelnidipine in Diabetic Apolipoprotein E-Deficient Mice"],"prefix":"10.1620","volume":"228","author":[{"given":"Kazuki","family":"Noda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Hosoya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sota","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Fukumoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"622","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2011.67"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M211926200"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000146672.10582.17"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2007.03.023"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000140265.21608.8E"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000239569.99126.37"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Gandhi, S., Srinivasan, B.P. &amp; Akarte, A.S. (2012) Effective blockade of RAAS by combination of aliskiren and olmesartan improves glucose homeostasis, glomerular filtration rate along with renal variables in streptozotocin induced diabetic rats. <i>Euro. J. Pharm. Sci.<\/i>, <b>46<\/b>, 32-42.","DOI":"10.1016\/j.ejps.2012.02.002"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Honda, H., Hosaka, N., Aoshima, Y., Hirai, Y., Michihata, T. &amp; Akizawa, T. (2012) Olmesartan medoxomil is associated with decreased plasma AGEs, pentosidine, and N-(epsilon)-carboxymethyl-lysine levels in hemodialysis patients. <i>Clin. Exp. Hypertens<\/i>., <b>34<\/b>, 17-23.","DOI":"10.3109\/10641963.2011.628726"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Hosoya, M., Ohashi, J., Sawada, A., Takaki, A. &amp; Shimokawa, H. (2010) Combination therapy with olmesartan and azelnidipine improves EDHF-mediated responses in diabetic apolipoprotein E-deficient mice. <i>Circ. J<\/i>., <b>74<\/b>, 798-806.","DOI":"10.1253\/circj.CJ-09-0862"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.02.06.db05-1164"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2008.344"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-10-0444"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000113627.08110.6f"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Kandler, M.R., Mah, G.T., Tejani, A.M., Stabler, S.N. &amp; Salzwedel, D.M. (2011) Hydralazine for essential hypertension. <i>Cochrane Database Syst Rev<\/i>, CD004934.","DOI":"10.1002\/14651858.CD004934.pub4"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000125114.88079.96"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Kennedy, J.M. &amp; Zochodne, D.W. (2000) The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. <i>Brain<\/i>, <b>123<\/b>, 2118-2129.","DOI":"10.1093\/brain\/123.10.2118"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Knock, G.A. &amp; Ward, J.P. (2011) Redox regulation of protein kinases as a modulator of vascular function. <i>Antioxid. Redox Signal.<\/i>, <b>15<\/b>, 1531-1547.","DOI":"10.1089\/ars.2010.3614"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-11-0141"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.26.201"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Libby, P., Okamoto, Y., Rocha, V.Z. &amp; Folco, E. (2010) Inflammation in atherosclerosis: transition from theory to practice. <i>Circ. J<\/i>., <b>74<\/b>, 213-220.","DOI":"10.1253\/circj.CJ-09-0706"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29881"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Luscher, T.F., Pieper, M., Tendera, M., Vrolix, M., Rutsch, W., van den Branden, F., Gil, R., Bischoff, K.O., Haude, M., Fischer, D., Meinertz, T. &amp; Munzel, T. (2009) A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. <i>Eur. Heart J<\/i>., <b>30<\/b>, 1590-1597.","DOI":"10.1093\/eurheartj\/ehp151"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.05.061"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Matsui, T., Yamagishi, S., Ueda, S., Nakamura, K., Imaizumi, T., Takeuchi, M. &amp; Inoue, H. (2007) Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-induced monocyte chemoattractant protein-1 expression in mesangial cells through downregulation of receptor for AGEs via peroxisome proliferator-activated receptor-gamma activation. <i>J. Int. Med. Res<\/i>., <b>35<\/b>, 482-489.","DOI":"10.1177\/147323000703500407"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.24.8467-8477.2002"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000180902.78230.fd"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000159657.93922.cb"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Nakamura, T., Sato, E., Fujiwara, N., Kawagoe, Y., Koide, H., Ueda, Y., Takeuchi, M. &amp; Yamagishi, S. (2011) Calcium channel blocker inhibition of AGE and RAGE axis limits renal injury in nondiabetic patients with stage I or II chronic kidney disease. <i>Clin. Cardiol<\/i>., <b>34<\/b>, 372-377.","DOI":"10.1002\/clc.20885"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Nakano, K., Egashira, K., Ohtani, K., Gang, Z., Iwata, E., Miyagawa, M. &amp; Sunagawa, K. (2008) Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice. <i>Atherosclerosis<\/i>, <b>196<\/b>, 172-179.","DOI":"10.1016\/j.atherosclerosis.2007.03.036"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000062961.76776.C1"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Rashid, M., Tawara, S., Fukumoto, Y., Seto, M., Yano, K. &amp; Shimokawa, H. (2009) Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors. <i>Circ. J<\/i>., <b>73<\/b>, 361-370.","DOI":"10.1253\/circj.CJ-08-0817"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Ricardo, S.D., van Goor, H. &amp; Eddy, A.A. (2008) Macrophage diversity in renal injury and repair. <i>J. Clin. Invest<\/i>., <b>118<\/b>, 3522-3530.","DOI":"10.1172\/JCI36150"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Schmidt, A.M., Yan, S.D., Wautier, J.L. &amp; Stern, D. (1999) Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. <i>Circ. Res<\/i>., <b>84<\/b>, 489-497.","DOI":"10.1161\/01.RES.84.5.489"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Shimokawa, H. (1999) Primary endothelial dysfunction: atherosclerosis. <i>J. Mol. Cell. Cardiol<\/i>., <b>31<\/b>, 23-37.","DOI":"10.1006\/jmcc.1998.0841"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Sukumaran, V., Watanabe, K., Veeraveedu, P.T., Gurusamy, N., Ma, M., Thandavarayan, R.A., Lakshmanan, A.P., Yamaguchi, K., Suzuki, K. &amp; Kodama, M. (2011) Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis. <i>Int. J. Biol. Sci<\/i>., <b>7<\/b>, 154-167.","DOI":"10.7150\/ijbs.7.154"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1097\/01.hjh.0000173521.91104.5f"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Takaki, A., Morikawa, K., Tsutsui, M., Murayama, Y., Tekes, E., Yamagishi, H., Ohashi, J., Yada, T., Yanagihara, N. &amp; Shimokawa, H. (2008) Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. <i>J. Exp. Med<\/i>., <b>205<\/b>, 2053-2063.","DOI":"10.1084\/jem.20080106"},{"key":"38","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M001235200"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000157409.88971.fc"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Vanhoutte, P.M. (2009) Endothelial dysfunction: the first step toward coronary arteriosclerosis. <i>Circ. J<\/i>., <b>73<\/b>, 595-601.","DOI":"10.1253\/circj.CJ-08-1169"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Wautier, M.P., Chappey, O., Corda, S., Stern, D.M., Schmidt, A.M. &amp; Wautier, J.L. (2001) Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. <i>Am. J. Physiol. Endocrinol. Metab<\/i>., <b>280<\/b>, E685-694.","DOI":"10.1152\/ajpendo.2001.280.5.E685"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L. &amp; Ferrante, A.W. Jr. (2003) Obesity is associated with macrophage accumulation in adipose tissue. <i>J. Clin. Invest<\/i>., <b>112<\/b>, 1796-1808.","DOI":"10.1172\/JCI200319246"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.146076"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2007.05.001"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.112292"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0437-7"}],"container-title":["The Tohoku Journal of Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/228\/4\/228_305\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T19:50:17Z","timestamp":1619639417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/tjem\/228\/4\/228_305\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1620\/tjem.228.305","relation":{},"ISSN":["0040-8727","1349-3329"],"issn-type":[{"value":"0040-8727","type":"print"},{"value":"1349-3329","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}